<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">medlit</journal-id><journal-title-group><journal-title xml:lang="ru">Гигиена и санитария</journal-title><trans-title-group xml:lang="en"><trans-title>Hygiene and Sanitation</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">0016-9900</issn><issn pub-type="epub">2412-0650</issn><publisher><publisher-name>Federal Scientific Center of Hygiene named after F.F. Erisman</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.47470/0016-9900-2022-101-12-1482-1487</article-id><article-id custom-type="elpub" pub-id-type="custom">medlit-2747</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>МЕДИЦИНА ТРУДА</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>OCCUPATIONAL HEALTH</subject></subj-group></article-categories><title-group><article-title>Факторы риска сердечно-сосудистых заболеваний у работников металлообрабатывающего производства</article-title><trans-title-group xml:lang="en"><trans-title>Cardiovascular risk factors in metalworking industry workers</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4234-7056</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Заикина</surname><given-names>Инна Викторовна</given-names></name><name name-style="western" xml:lang="en"><surname>Zaikina</surname><given-names>Inna V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Канд. мед. наук, ст. науч. сотр. отд. медико-профилактических и инновационных технологий Саратовского МНЦ гигиены ФБУН «ФНЦ медико-профилактических технологий управления рисками здоровью населения», 410022, Саратов.</p><p>e-mail: innaza2@mail.ru</p></bio><bio xml:lang="en"><p>MD, PhD, Senior Research Officer, Department of Medical Preventive and Innovative Technologies, Saratov Hygiene Medical Research Center of the Federal Scientific Center Medical and Preventive Health Risk Management Technologies, Saratov, 410022, Russian Federation.</p><p>e-mail: innaza2@mail.ru</p></bio><email xlink:type="simple">innaza2@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4099-9368</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Комлева</surname><given-names>Н. Е.</given-names></name><name name-style="western" xml:lang="en"><surname>Komleva</surname><given-names>Nataliia E.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8220-145X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Мазилов</surname><given-names>С. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Mazilov</surname><given-names>Svyatoslav I.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2067-3830</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Поздняков</surname><given-names>М. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Pozdnyakov</surname><given-names>Michail V.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5817-2994</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Райкин</surname><given-names>С. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Raykin</surname><given-names>Sergey S.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8980-5117</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Долич</surname><given-names>В. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Dolich</surname><given-names>Vladimir N.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5749-2382</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Райкова</surname><given-names>С. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Rajkova</surname><given-names>Svetlana V.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Саратовский медицинский научный центр гигиены ФБУН «Федеральный научный центр медико-профилактических технологий управления рисками здоровью населения» Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Saratov Hygiene Medical Research Center of the Federal Scientific Center for Medical and Preventive Health Risk Management Technologies</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Саратовский медицинский научный центр гигиены ФБУН «Федеральный научный центр медико-профилактических технологий управления рисками здоровью населения» Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека; ФГБОУ ВО «Саратовский государственный медицинский университет имени В.И. Разумовского» Министерства здравоохранения Российской Федерации</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Saratov Hygiene Medical Research Center of the Federal Scientific Center for Medical and Preventive Health Risk Management Technologies; Saratov State Medical University named after V.I. Razumovsky</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2022</year></pub-date><pub-date pub-type="epub"><day>13</day><month>01</month><year>2023</year></pub-date><volume>101</volume><issue>12</issue><fpage>1482</fpage><lpage>1487</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Заикина И.В., Комлева Н.Е., Мазилов С.И., Поздняков М.В., Райкин С.С., Долич В.Н., Райкова С.В., 2023</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="ru">Заикина И.В., Комлева Н.Е., Мазилов С.И., Поздняков М.В., Райкин С.С., Долич В.Н., Райкова С.В.</copyright-holder><copyright-holder xml:lang="en">Zaikina I.V., Komleva N.E., Mazilov S.I., Pozdnyakov M.V., Raykin S.S., Dolich V.N., Rajkova S.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.rjhas.ru/jour/article/view/2747">https://www.rjhas.ru/jour/article/view/2747</self-uri><abstract><sec><title>Введение</title><p>Введение. Многие факторы сердечно-сосудистого риска ассоциированы с неалкогольной жировой болезнью печени, которую признают одним из предикторов сердечно-сосудистых заболеваний. Учитывая, что длительное время неалкогольная жировая болезнь печени протекает бессимптомно, весьма важно определение взаимосвязей между различными факторами, участвующими в формировании патологии, для раннего выявления и профилактики сердечно-сосудистых заболеваний у лиц трудоспособного возраста.</p></sec><sec><title>Материалы и методы</title><p>Материалы и методы. В рамках поперечного исследования изучена распространённость факторов сердечно-сосудистого риска у работников металлообрабатывающего производства. Проанализированы индекс массы тела, показатели липидного профиля, глюкоза, гликированный гемоглобин, результаты ультразвукового исследования печени, индекс накопления липидов, физическая активность.</p></sec><sec><title>Результаты</title><p>Результаты. Стеатоз печени выявлен у 37% участников исследования. У 19% лиц стеатоз печени обнаружен при нормальном индексе массы тела с преобладанием в группе лиц пожилого возраста; значения липидного профиля статистически значимо выше в группе лиц с диагностированным стеатозом печени: общий холестерин (р &lt; 0,001), триглицериды (р &lt; 0,001), индекс атерогенности (р &lt; 0,001), а также гипергликемия (р &lt; 0,001). Коэффициент накопления липидов увеличивается с возрастом и повышен у лиц со стеатозом и ожирением. В группе лиц со стеатозом печени статистически значимо преобладают лица с низкой физической активностью.</p></sec><sec><title>Ограничения исследования</title><p>Ограничения исследования. Исследование имеет региональные (Саратовская область) и профессиональные (работники металлообрабатывающего производства) ограничения.</p></sec><sec><title>Заключение</title><p>Заключение. Результаты исследования показали высокую распространённость стеатоза печени среди работников металлообрабатывающего производства со значительным преобладанием в группе мужчин пожилого возраста. Установленные взаимосвязи изучаемых факторов сердечно-сосудистого риска подтверждают значительные метаболические расстройства у работников металлообрабатывающего производства, что в условиях дополнительного воздействия производственных факторов может потенцировать развитие сердечно-сосудистых заболеваний и их осложнений, а также быть причиной фатальных случаев, в том числе на производстве.</p><p>Соблюдение этических стандартов. Исследования проведены с соблюдением требований конфиденциальности персональных данных, этических норм и принципов проведения медицинских исследований с участием человека, изложенных в Хельсинкской декларации Всемирной медицинской ассоциации (ред. 2013 г.). Исследование выполнено с разрешения локального этического комитета Саратовского МНЦ гигиены ФБУН «ФНЦ медико-профилактических технологий управления рисками здоровью населения» (протокол № 11 от 01.08.2022 г.).</p></sec><sec><title>Согласие пациентов</title><p>Согласие пациентов. Каждый участник исследования (или его законный представитель) дал информированное добровольное письменное согласие на участие в исследовании и публикацию персональной медицинской информации в обезличенной форме в журнале «Гигиена и санитария».</p></sec><sec><title>Участие авторов</title><p>Участие авторов: Заикина И.В. — концепция и дизайн исследования, сбор материала и обработка данных, написание текста;Комлева Н.Е. — концепция и дизайн исследования, редактирование; Мазилов С.И. — сбор материала и обработка данных, статистический анализ; Поздняков М.В. — сбор материала и обработка данных, написание текста; Райкин С.С. — сбор материала и обработка данных, статистический анализ; Долич В.Н. — сбор материала и обработка данных, статистический анализ; Райкова С.В. — сбор материала и обработка данных, написание текста. Все соавторы — утверждение окончательного варианта статьи, ответственность за целостность всех частей статьи.</p></sec><sec><title>Конфликт интересов</title><p>Конфликт интересов. Авторы декларируют отсутствие явных и потенциальных конфликтов интересов в связи с публикацией данной статьи.</p></sec><sec><title>Финансирование</title><p>Финансирование. Исследование не имело спонсорской поддержки.</p></sec><sec><title>Поступила</title><p>Поступила: 11.10.2022 / Принята к печати: 08.12.2022 / Опубликована: 12.01.2023</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Introduction</title><p>Introduction. Many cardiovascular risk factors are associated with non-alcoholic fatty liver disease, which is recognized as one of the predictors of cardiovascular diseases. Considering non-alcoholic fatty liver disease to be asymptomatic for a long time, it is very important to determine the relationships between various factors involved in the formation of pathology to early detect and prevent cardiovascular diseases in people of working age.</p></sec><sec><title>Materials and methods</title><p>Materials and methods. As part of a cross-sectional study, the prevalence of cardiovascular risk factors in metalworking workers was studied. The body mass index, lipid profile indicators, glucose, glycated hemoglobin, liver ultrasound results, lipid accumulation index, physical activity were analyzed.</p></sec><sec><title>Results</title><p>Results. The study revealed the presence of liver steatosis in 37% of the study participants. In 19%, liver steatosis was detected with a normal body mass index with a predominance in the “elderly” group; the values of the lipid profile are statistically significantly higher in the group of people diagnosed with liver steatosis: total cholesterol (p &lt; 0.001), triglycerides (p &lt; 0.001), atherogenicity index (p &lt; 0.001); and hyperglycemia (p &lt; 0.001). The coefficient of lipid accumulation increases with age, presence of steatosis, and obesity. In the group of persons with hepatic steatosis, persons with low physical activity significantly predominate.</p></sec><sec><title>Limitations</title><p>Limitations. The study has regional (Saratov region) and occupational (workers of the metalworking industry) limitations.</p></sec><sec><title>Conclusion</title><p>Conclusion. The results of the study showed a high prevalence of liver steatosis among metalworking workers, mainly in elderly men. The established interrelations of the studied cardiovascular risk factors confirm significant cardiometabolic disorders in metalworking workers, which, under conditions of additional exposure to production factors, can potentiate the development of cardiovascular diseases and their complications, cause fatal cases, including at work.</p><p>Compliance with ethical standards. Research was conducted in compliance with the requirements of confidentiality of personal data, ethical standards, and principles for conducting medical research involving humans, set out in the Declaration of Helsinki of the World Medical Association of the latest (2008) revision. The study was carried out with the permission of the local ethical committee of the Saratov MNC of Hygiene of the Federal State Budgetary Institution "FNC of Medical and Preventive Technologies of Public Health Risk Management" (Protocol No. 11 of 01.08.2022).</p></sec><sec><title>Patient consent</title><p>Patient consent. Each participant of the study (or his/her legal representative) gave informed voluntary written consent to participate in the study and publish personal medical information in an impersonal form in the journal "Gigiena i Sanitariya (Hygiene and Sanitation, Russian journal)".</p></sec><sec><title>Contribution</title><p>Contribution: Zaikina I.V. — the concept and design of the study, collection and processing of material, writing a text; Komleva N.E. — the concept and design of the study, editing; Mazilov S.I. — collection and processing of material, statistical processing; Pozdnyakov M.V. — collection and processing of material, writing a text; Raykin S.S. — collection and processing of material, statistical processing; Dolich V.N. — collection and processing of material, statistical processing; Raikova S.V. — collection and processing of material, writing a text. All authors are responsible for the integrity of all parts of the manuscript and approval of the manuscript final version. </p></sec><sec><title>Conflict of interest</title><p>Conflict of interest. The authors declare no conflict of interest.</p></sec><sec><title>Acknowledgment</title><p>Acknowledgment. The study had no sponsorship. </p></sec><sec><title>Received</title><p>Received: October 11, 2022 / Accepted: December 8, 2022 / Published: January 12, 2023 </p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>работники металлообрабатывающего производства</kwd><kwd>неалкогольная жировая болезни печени</kwd><kwd>факторы риска</kwd><kwd>сердечно-сосудистые заболевания</kwd></kwd-group><kwd-group xml:lang="en"><kwd>workers of the metalworking industry</kwd><kwd>non-alcoholic fatty liver disease</kwd><kwd>risk factors</kwd><kwd>cardiovascular diseases</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">WHO. Noncommunicable Diseases: Mortality; 2019. Available at: https://www.who.int/gho/ncd/mortality_morbidity/en/</mixed-citation><mixed-citation xml:lang="en">WHO. Noncommunicable Diseases: Mortality; 2019. Available at: https://www.who.int/gho/ncd/mortality_morbidity/en/</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">World Health Organization. Noncommunicable Diseases (NCD) Country Profiles; 2014. Available at: https://www.who.int/publications/i/item/9789241507509</mixed-citation><mixed-citation xml:lang="en">World Health Organization. Noncommunicable Diseases (NCD) Country Profiles; 2014. Available at: https://www.who.int/publications/i/item/9789241507509</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Кобякова О.С., Деев И.А., Куликов Е.С., Старовойтова Е.А., Малых Р.Д., Балаганская М.А. и др. Хронические неинфекционные заболевания: эффекты сочетанного влияния факторов риска. Профилактическая медицина. 2019; 22(2): 45-50. https://doi.org/10.17116/profmed20192202145</mixed-citation><mixed-citation xml:lang="en">Kobyakova O.S., Deev I.A., Kulikov E.S., Starovoytova E.A., Malykh R.D., Balaganskaya M.A., et al. Chronic noncommunicable diseases: combined effects of risk factors. Profilakticheskaya meditsina. 2019; 22(2): 45–50. https://doi.org/10.17116/profmed20192202145 (in Russian)</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Lim S., Oh T.J., Koh K.K. Mechanistic link between nonalcoholic fatty liver disease and cardiometabolic disorders. J. Cardiol. 2015; 201: 408-14. https://doi.org/10.1016/j.ijcard.2015.08.107</mixed-citation><mixed-citation xml:lang="en">Lim S., Oh T.J., Koh K.K. Mechanistic link between nonalcoholic fatty liver disease and cardiometabolic disorders. J. Cardiol. 2015; 201: 408–14. https://doi.org/10.1016/j.ijcard.2015.08.107</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Estes C., Anstee Q.M., Arias-Loste M.T., Bantel H., Bellentani S., Caballeria J., et al. Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030. J. Hepatol. 2018; 69(4): 896-904. https://doi.org/10.1016/j.jhep.2018.05.036</mixed-citation><mixed-citation xml:lang="en">Estes C., Anstee Q.M., Arias-Loste M.T., Bantel H., Bellentani S., Caballeria J., et al. Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030. J. Hepatol. 2018; 69(4): 896–904. https://doi.org/10.1016/j.jhep.2018.05.036</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Mantovani A., Csermely A., Petracca G., Beatrice G., Corey K.E., Simon T.G., et al. Non-alcoholic fatty liver disease and risk of fatal and non-fatal cardiovascular events: an updated systematic review and meta-analysis. Lancet Gastroenterol. Hepatol. 2021; 6(11): 903-13. https://doi.org/10.1016/S2468-1253(21)00308-3</mixed-citation><mixed-citation xml:lang="en">Mantovani A., Csermely A., Petracca G., Beatrice G., Corey K.E., Simon T.G., et al. Non-alcoholic fatty liver disease and risk of fatal and non-fatal cardiovascular events: an updated systematic review and meta-analysis. Lancet Gastroenterol. Hepatol. 2021; 6(11): 903–13. https://doi.org/10.1016/S2468-1253(21)00308-3</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Ивашкин В.Т., Драпкина О.М., Маев И.В., Трухманов А.С., Блинов Д.В., Пальгова Л.К. и др. Распространенность неалкогольной жировой болезни печени у пациентов амбулаторно-поликлинической практики в Российской Федерации: результаты исследования DIREG 2. Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2015; 25(6): 31-41</mixed-citation><mixed-citation xml:lang="en">Ivashkin V.T., Drapkina O.M., Maev I.V., Trukhmanov A.S., Blinov D.V., Pal’gova L.K., et al. Prevalence of non-alcoholic fatty liver disease in out-patients of the Russian Federation: DIREG 2 study results. Rossiyskiy zhurnal gastroenterologii, gepatologii, koloproktologii. 2015; 25(6): 31–41. (in Russian)</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Lin Y., Gong X., Li X., Shao C., Wu T., Li M., at al. Distinct cause of death profiles of hospitalized non-alcoholic fatty liver disease: a 10 years’ cross-sectional multicenter study in China. Front. Med. (Lausanne). 2021; 7: 584396. https://doi.org/10.3389/fmed.2020.584396</mixed-citation><mixed-citation xml:lang="en">Lin Y., Gong X., Li X., Shao C., Wu T., Li M., at al. Distinct cause of death profiles of hospitalized non-alcoholic fatty liver disease: a 10 years’ cross-sectional multicenter study in China. Front. Med. (Lausanne). 2021; 7: 584396. https://doi.org/10.3389/fmed.2020.584396</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Niederseer D., Wernly S., Bachmayer S., Wernly B., Bakula A., Huber-Schönauer U., et al. Diagnosis of Non-Alcoholic Fatty Liver Disease (NAFLD) is independently associated with cardiovascular risk in a large Austrian screening cohort. J. Clin. Med. 2020; 9(4): 1065. https://doi.org/:10.3390/jcm9041065</mixed-citation><mixed-citation xml:lang="en">Niederseer D., Wernly S., Bachmayer S., Wernly B., Bakula A., Huber-Schönauer U., et al. Diagnosis of Non-Alcoholic Fatty Liver Disease (NAFLD) is independently associated with cardiovascular risk in a large Austrian screening cohort. J. Clin. Med. 2020; 9(4): 1065. https://doi.org/:10.3390/jcm9041065</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Васильев С.В. Основы возрастной и конституциональной антропологии. М.; 1996</mixed-citation><mixed-citation xml:lang="en">Vasil’ev S.V. Fundamentals of Age and Constitutional Anthropology [Osnovy vozrastnoy i konstitutsional’noy antropologii]. Moscow; 1996. (in Russian)</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Kahn H.S. The «lipid accumulation product» performs better than the body mass index for recognizing cardiovascular risk: a population-based comparison. BMC Cardiovasc. Disord. 2005; 5: 26. https://doi.org/10.1186/1471-2261-5-26</mixed-citation><mixed-citation xml:lang="en">Kahn H.S. The «lipid accumulation product» performs better than the body mass index for recognizing cardiovascular risk: a population-based comparison. BMC Cardiovasc. Disord. 2005; 5: 26. https://doi.org/10.1186/1471-2261-5-26</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">International Physical Activity Questionnaire; (2005). Available at: https://sites.google.com/site/theipaq/scoring-protocol</mixed-citation><mixed-citation xml:lang="en">International Physical Activity Questionnaire; (2005). Available at: https://sites.google.com/site/theipaq/scoring-protocol</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Bril F., Ortiz-Lopez C., Lomonaco R., Orsak B., Freckleton M., Chintapalli K., et al. Clinical value of liver ultrasound for the diagnosis of nonalcoholic fatty liver disease in overweight and obese patients. Liver Int. 2015; 35(9): 2139-46. https://doi.org/10.1111/liv.12840</mixed-citation><mixed-citation xml:lang="en">Bril F., Ortiz-Lopez C., Lomonaco R., Orsak B., Freckleton M., Chintapalli K., et al. Clinical value of liver ultrasound for the diagnosis of nonalcoholic fatty liver disease in overweight and obese patients. Liver Int. 2015; 35(9): 2139–46. https://doi.org/10.1111/liv.12840</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Пономарева Т.А., Воробьева А.А., Власова Е.М., Носов А.Е., Устинова О.Ю. Метаболические нарушения и функциональное состояние печени у работников предприятий нефтедобычи. Вестник Пермского университета. Серия: Биология. 2019; (4): 488-95. https://doi.org/10.17072/1994-9952-2019-4-488-495</mixed-citation><mixed-citation xml:lang="en">Ponomareva T.A., Vorob’eva A.A., Vlasova E.M., Nosov A.E., Ustinova O.Yu. Metabolic disorders and functional status of the liver in workers of oil production enterprises. Vestnik Permskogo universiteta. Seriya: Biologiya. 2019; (4): 488–95. https://doi.org/10.17072/1994-9952-2019-4-488-495 (in Russian)</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Михайлова Н.В., Петрунько И.Л. Распространённость и структура хронических заболеваний печени различной этиологии на сельском терапевтическом участке Иркутской области. Экспериментальная и клиническая гастроэнтерология. 2020; 176(4): 65-71. https://doi.org/10.31146/1682-8658-ecg-176-4-65-71</mixed-citation><mixed-citation xml:lang="en">Mikhaylova N.V., Petrun’ko I.L. Prevalence and structure of fatty liver disease of varying etiology at the rural therapeutic stretch. Eksperimental’naya i klinicheskaya gastroenterologiya. 2020; 176(4): 65–71. https://doi.org/10.31146/1682-8658-ecg-176-4-65-71 (in Russian)</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Пальгова Л.К., Барановский А.Ю., Ушакова Т.И., Юркина, А.С., Блинов Д.В. Эпидемиологические особенности неалкогольной жировой болезни печени в Северо-Западном регионе России (результаты открытого многоцентрового проспективного исследования DIREG 2). Вестник Санкт-Петербургского университета. Медицина. 2017; 12(2): 118-35. https://doi.org/10.21638/11701/spbu11.2017.201</mixed-citation><mixed-citation xml:lang="en">Pal’gova L.K., Baranovskiy A.Yu., Ushakova T.I., Yurkina, A.S., Blinov D.V. Epidemiological features of non-alcoholic fatty liver disease in the north-west region of Russia (results of a open multicenter prospective study DIREG 2). Vestnik Sankt-Peterburgskogo universiteta. Meditsina. 2017; 12(2): 118–35. https://doi.org/10.21638/11701/spbu11.2017.201 (in Russian)</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Eguchi Y., Wong G., Lee E.I., Akhtar O., Lopes R., Sumida Y. Epidemiology of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in Japan: A focused literature review. JGH Open. 2020; 4(5): 808-17. https://doi.org/10.1002/jgh3.12349</mixed-citation><mixed-citation xml:lang="en">Eguchi Y., Wong G., Lee E.I., Akhtar O., Lopes R., Sumida Y. Epidemiology of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in Japan: A focused literature review. JGH Open. 2020; 4(5): 808–17. https://doi.org/10.1002/jgh3.12349</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Yang J.D., Abdelmalek M.F., Guy C.D., Gill R.M., Lavine J.E., Yates K., et al. Patient Sex, Reproductive Status, and Synthetic Hormone Use Associate with Histologic Severity of Nonalcoholic Steatohepatitis. Clin. Gastroenterol. Hepatol. 2017; 15(1): 127-31.e2. https://doi.org/10.1016/j.cgh.2016.07.03417</mixed-citation><mixed-citation xml:lang="en">Yang J.D., Abdelmalek M.F., Guy C.D., Gill R.M., Lavine J.E., Yates K., et al. Patient Sex, Reproductive Status, and Synthetic Hormone Use Associate with Histologic Severity of Nonalcoholic Steatohepatitis. Clin. Gastroenterol. Hepatol. 2017; 15(1): 127–31.e2. https://doi.org/10.1016/j.cgh.2016.07.03417</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Lazo M., Hernaez R., Eberhardt M.S., Bonekamp S., Kamel I., Guallar Е., et al. Prevalence of nonalcoholic fatty liver disease in the United States: the Third National Health and Nutrition Examination Survey, 1988-1994. Am. J. Epidemiol. 2013; 178(1): 38-45. https://doi.org/10.1093/aje/kws44833</mixed-citation><mixed-citation xml:lang="en">Lazo M., Hernaez R., Eberhardt M.S., Bonekamp S., Kamel I., Guallar Е., et al. Prevalence of nonalcoholic fatty liver disease in the United States: the Third National Health and Nutrition Examination Survey, 1988-1994. Am. J. Epidemiol. 2013; 178(1): 38–45. https://doi.org/10.1093/aje/kws44833</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Doycheva I., Watt K.D., Rifai G., Abou Mrad R., Lopez R., Zein N.N., et al. Increasing burden of chronic liver disease among adolescents and young adults in the USA: A silent epidemic. Dig. Dis. Sci. 2017; 62(5): 1373-80. https://doi.org/10.1007/s10620-017-4492-3</mixed-citation><mixed-citation xml:lang="en">Doycheva I., Watt K.D., Rifai G., Abou Mrad R., Lopez R., Zein N.N., et al. Increasing burden of chronic liver disease among adolescents and young adults in the USA: A silent epidemic. Dig. Dis. Sci. 2017; 62(5): 1373–80. https://doi.org/10.1007/s10620-017-4492-3</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Sarwar R., Pierce N., Koppe S. Obesity and nonalcoholic fatty liver disease: current perspectives. Diabetes. Metab. Syndr. Obes. 2018; 11: 533-42. https://doi.org/10.2147/DMSO.S146339</mixed-citation><mixed-citation xml:lang="en">Sarwar R., Pierce N., Koppe S. Obesity and nonalcoholic fatty liver disease: current perspectives. Diabetes. Metab. Syndr. Obes. 2018; 11: 533–42. https://doi.org/10.2147/DMSO.S146339</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Stefan N., Schick F., Häring H.U. Causes, characteristics and consequences of metabolically unhealthy normal weight in humans. Cell Metabol. 2017; 26(2): 292-300. https://doi.org/10.1016/j.cmet.2017.07.008</mixed-citation><mixed-citation xml:lang="en">Stefan N., Schick F., Häring H.U. Causes, characteristics and consequences of metabolically unhealthy normal weight in humans. Cell Metabol. 2017; 26(2): 292–300. https://doi.org/10.1016/j.cmet.2017.07.008</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Machado M.V., Cortez-Pinto H. Diet, microbiota, obesity, and NAFLD: A dangerous quartet.Int. J. Mol. Sci. 2016; 17(4): 481. https://doi.org/10.3390/ijms17040481</mixed-citation><mixed-citation xml:lang="en">Machado M.V., Cortez-Pinto H. Diet, microbiota, obesity, and NAFLD: A dangerous quartet. Int. J. Mol. Sci. 2016; 17(4): 481. https://doi.org/10.3390/ijms17040481</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Byrne C.D., Targher G. NAFLD: a multisystem disease. J. Hepatol. 2015; 62(1 Suppl.): 47-64. https://doi.org/10.1016/j.jhep.2014.12.012</mixed-citation><mixed-citation xml:lang="en">Byrne C.D., Targher G. NAFLD: a multisystem disease. J. Hepatol. 2015; 62(1 Suppl.): 47–64. https://doi.org/10.1016/j.jhep.2014.12.012</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Targher G., Byrne C.D., Lonardo A., Zoppini G., Barbui C. Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis. J. Hepatol. 2016; 65(3): 589-600. https://doi.org/10.1016/j.jhep.2016.05.013</mixed-citation><mixed-citation xml:lang="en">Targher G., Byrne C.D., Lonardo A., Zoppini G., Barbui C. Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis. J. Hepatol. 2016; 65(3): 589–600. https://doi.org/10.1016/j.jhep.2016.05.013</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Bedogni G., Kahn H.S., Bellentani S., Tiribelli C. A simple index of lipid overaccumulation is a good marker of liver steatosis. BMC Gastroenterol. 2010; 10: 98. https://doi.org/10.1186/1471-230X-10-98</mixed-citation><mixed-citation xml:lang="en">Bedogni G., Kahn H.S., Bellentani S., Tiribelli C. A simple index of lipid overaccumulation is a good marker of liver steatosis. BMC Gastroenterol. 2010; 10: 98. https://doi.org/10.1186/1471-230X-10-98</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Зайцева Н.В., Костарев В.Г., Лужецкий К.П., Носов А.Е., Устинова О.Ю., Чигвинцев В.М. Метаболические нарушения у работников шахты по добыче хрома. Гигиена и санитария. 2021; 100(10): 1095-102. https://doi.org/10.47470/0016-9900-2021-100-10-1095-1102</mixed-citation><mixed-citation xml:lang="en">Zaytseva N.V., Kostarev V.G., Luzhetskiy K.P., Nosov A.E., Ustinova O.Yu., Chigvintsev V.M. Features of metabolic disorders in chromium mine workers. Gigiena i Sanitaria (Hygiene and Sanitation, Russian journal). 2021; 100(10): 1095–102. https://doi.org/10.47470/0016-9900-2021-100-10-1095-1102 (in Russian)</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Ray L., Ravichandran K., Nanda S.K.Comparison of lipid accumulation product index with body mass index and waist circumference as a predictor of metabolic syndrome in Indian population. Metab. Syndr. Relat. Disord. 2018; 16(5): 240-5. https://doi.org/10.1089/met.2017.0119</mixed-citation><mixed-citation xml:lang="en">Ray L., Ravichandran K., Nanda S.K. Comparison of lipid accumulation product index with body mass index and waist circumference as a predictor of metabolic syndrome in Indian population. Metab. Syndr. Relat. Disord. 2018; 16(5): 240–5. https://doi.org/10.1089/met.2017.0119</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Канева А.М., Потолицына Н.Н., Бойко Е.Р. Диапазон варьирования значений индекса накопления липидов (lipid accumulation product, LAP) у здоровых жителей европейского Севера России. Ожирение и метаболизм. 2020; 17(2): 179-86. https://doi.org/10.14341/omet11278</mixed-citation><mixed-citation xml:lang="en">Kaneva A.M., Potolitsyna N.N., Boyko E.R. Range of values for lipid accumulation product (lap) in healthy residents of the European North of Russia. Ozhirenie i metabolizm. 2020; 17(2): 179–86. https://doi.org/10.14341/omet11278 (in Russian)</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Machado M.V. Aerobic exercise in the management of metabolic dysfunction associated fatty liver disease. Diabetes. Metab. Syndr. Obes. 2021; 14: 3627-45. https://doi.org/10.2147/DMSO.S304357</mixed-citation><mixed-citation xml:lang="en">Machado M.V. Aerobic exercise in the management of metabolic dysfunction associated fatty liver disease. Diabetes. Metab. Syndr. Obes. 2021; 14: 3627–45. https://doi.org/10.2147/DMSO.S304357</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
